Molecular dynamics of Mycobacterium tuberculosis KasA: implications for inhibitor and substrate binding and consequences for drug design

Inhibition of the production of fatty acids as essential components of the mycobacterial cell wall has been an established way of fighting tuberculosis for decades. However, increasing resistances and an outdated medical treatment call for the validation of new targets involved in this crucial pathway. In this regard, the β-ketoacyl ACP synthase KasA is a promising enzyme. In this study, three molecular dynamics simulations based on the wildtype crystal structures of inhibitor bound and unbound KasA were performed in order to investigate the flexibility and conformational space of this target. We present an exhaustive analysis of the binding-site flexibility and representative pocket conformations that may serve as new starting points for structure-based drug design. We also revealed a mechanism which may account for the comparatively low binding affinity of thiolactomycin. Furthermore, we examined the behavior of water molecules within the binding pocket and provide recommendations how to handle them in the drug design process. Finally, we analyzed the dynamics of a channel that accommodates the long-chain fatty acid substrates and, thereby, propose a mechanism of substrate access to this channel and how products are most likely released.

[1]  Klaus R. Liedl,et al.  Consideration of Water and Solvation Effects in Virtual Screening , 2011 .

[2]  C. Volker,et al.  Purification and Biochemical Characterization of theMycobacterium tuberculosis β-Ketoacyl-acyl Carrier Protein Synthases KasA and KasB* , 2001, The Journal of Biological Chemistry.

[3]  L. Kremer,et al.  Conditional Depletion of KasA, a Key Enzyme of Mycolic Acid Biosynthesis, Leads to Mycobacterial Cell Lysis , 2005, Journal of bacteriology.

[4]  P. Beroza,et al.  Application of a pairwise generalized Born model to proteins and nucleic acids: inclusion of salt effects , 1999 .

[5]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[6]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[7]  Robert Stroud,et al.  Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. , 2006, Journal of medicinal chemistry.

[8]  P. Ortiz de Montellano,et al.  Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG. , 2005, Journal of the American Chemical Society.

[9]  C. Dye,et al.  The Population Dynamics and Control of Tuberculosis , 2010, Science.

[10]  David Alland,et al.  Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase , 2003, Journal of Biological Chemistry.

[11]  P. Ortiz de Montellano,et al.  Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. , 2007, Bioorganic & medicinal chemistry.

[12]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[13]  D Alland,et al.  Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes inMycobacterium tuberculosis * , 2000, The Journal of Biological Chemistry.

[14]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[15]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[16]  Gurdyal S Besra,et al.  Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis. , 2002, The Biochemical journal.

[17]  C. Vilchèze,et al.  Crystal Structure of the Mycobacterium tuberculosis Enoyl-ACP Reductase, InhA, in Complex with NAD+ and a C16 Fatty Acyl Substrate* , 1999, The Journal of Biological Chemistry.

[18]  P. Tonge,et al.  Crystal structures of Mycobacterium tuberculosis KasA show mode of action within cell wall biosynthesis and its inhibition by thiolactomycin. , 2009, Structure.

[19]  P. Tonge,et al.  Elucidation of the protonation states of the catalytic residues in mtKasA: implications for inhibitor design. , 2011, Biochemistry.

[20]  N. Oppenheimer,et al.  Structure and mechanism , 1989 .

[21]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[22]  P. Tonge,et al.  Slow Onset Inhibition of Bacterial β-Ketoacyl-acyl Carrier Protein Synthases by Thiolactomycin* , 2009, The Journal of Biological Chemistry.

[23]  Eric Arnoult,et al.  The challenge of new drug discovery for tuberculosis , 2011, Nature.

[24]  Catherine Vilchèze,et al.  The mechanism of isoniazid killing: clarity through the scope of genetics. , 2007, Annual review of microbiology.

[25]  I. Luque,et al.  Structural stability of binding sites: Consequences for binding affinity and allosteric effects , 2000, Proteins.

[26]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[27]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[28]  Jie J. Zheng,et al.  The Solution Structure of Acyl Carrier Protein from Mycobacterium tuberculosis * , 2002, The Journal of Biological Chemistry.

[29]  J. Ladbury Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design. , 1996, Chemistry & biology.

[30]  William R. Jacobs,et al.  Microbial Pathogenesis of Mycobacterium tuberculosis: Dawn of a Discipline , 2001, Cell.

[31]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[32]  Jun Wang,et al.  Platensimycin is a selective FabF inhibitor with potent antibiotic properties , 2006, Nature.

[33]  R. Heath,et al.  Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and Cerulenin , 2001, The Journal of Biological Chemistry.